Loomis Sayles & Co. L P Has $756,000 Stock Position in Cardinal Health, Inc. (NYSE:CAH)

Loomis Sayles & Co. L P increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 650.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,836 shares of the company’s stock after buying an additional 5,925 shares during the quarter. Loomis Sayles & Co. L P’s holdings in Cardinal Health were worth $756,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Pacer Advisors Inc. raised its stake in Cardinal Health by 4.7% during the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock worth $474,203,000 after buying an additional 191,568 shares during the period. ProShare Advisors LLC raised its stake in Cardinal Health by 5.1% during the 2nd quarter. ProShare Advisors LLC now owns 1,759,299 shares of the company’s stock worth $172,974,000 after buying an additional 85,247 shares during the period. Renaissance Technologies LLC increased its holdings in Cardinal Health by 7.1% during the 2nd quarter. Renaissance Technologies LLC now owns 1,683,447 shares of the company’s stock worth $165,517,000 after purchasing an additional 111,137 shares in the last quarter. American Century Companies Inc. increased its holdings in Cardinal Health by 17.7% during the 2nd quarter. American Century Companies Inc. now owns 1,610,968 shares of the company’s stock worth $158,390,000 after purchasing an additional 242,608 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in Cardinal Health by 2.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after purchasing an additional 33,388 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.1 %

Shares of CAH stock opened at $122.59 on Thursday. The firm has a 50 day moving average price of $114.29 and a two-hundred day moving average price of $106.29. The company has a market capitalization of $29.67 billion, a PE ratio of 23.85, a price-to-earnings-growth ratio of 1.52 and a beta of 0.60. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $126.14.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The business’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period last year, the business posted $1.73 earnings per share. As a group, research analysts expect that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a dividend of $0.5056 per share. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 annualized dividend and a yield of 1.65%. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CAH. Mizuho increased their target price on Cardinal Health from $110.00 to $120.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft raised their price objective on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday, November 4th. Barclays raised their price objective on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Evercore ISI raised their price objective on Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a report on Thursday, August 15th. Finally, UBS Group raised their price objective on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $123.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.